• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

activist investor

Bausch Health headquarters formerly Valeant
Pharma

Activist investor Icahn takes 34% interest in Bausch Health

The company discovered the size of activist investor Carl Icahn's economic interest after initiating a "poison pill" plan to ward off unwanted takeovers.
Zoey Becker Apr 22, 2025 6:39pm
Two people sit across from each other at a desk

Another activist investor sets its sights on Kenvue: Bloomberg

Mar 24, 2025 10:38am
fight gloves boxing punch ring tape fists

Investor group calls for strategy shift at struggling Amarin

Mar 20, 2025 11:00am
Pfizer CEO Albert Bourla

Pfizer avoids board nominations from Starboard: Bloomberg

Jan 27, 2025 2:45pm
locking horns

Assertio says activist investor's claims are 'without merit'

Nov 12, 2024 8:00am
Indivior Sublocade opioid use disorder treatment box

Top investor Oaktree calls for board shake-up at Indivior

Nov 8, 2024 10:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings